Researchers sought to determine whether treatment for CLL in veterans with targeted therapies would lead to longer survival than chemotherapy or monoclonal antibodies.
Researchers sought to determine whether combination therapy with DPd would benefit patients with relapsed or refractory multiple myeloma after receiving lenalidomide.
Researchers sought to determine the healthcare resource utilization, costs, and mortality associated with patients with polycythemia vera who had thromboembolic events.
Researchers sought to identify differences in features and outcomes for adolescents and young adults with Philadelphia-negative ALL who are treated under an adult protocol.
Researchers sought to determine whether PIPs would improve clinical outcomes compared with HyperCVAD among AYA patients with Philadelphia-negative ALL.
